Literature DB >> 2840451

Specific serum IgA, IgG and IgM antibody determination by a modified indirect ELISA-technique in primary and recurrent herpes simplex virus infection.

P Juto1, B Settergren.   

Abstract

Twenty-three patients with a herpetic infection as diagnosed by a positive culture of herpes simplex virus (HSV) were studied with respect to serological responses of IgA, IgG and IgM antibodies in paired serum samples by an indirect (sandwich) enzyme linked immunosorbent assay (ELISA). Eight of the patients had a primary infection and 15 a recurrent one. In the ELISA test a detergent treated cell lysate of HSV type 1 was used as antigen. In the IgM assay all sera were pretreated with antihuman IgG with the purpose to precipitate IgG of the samples. The conjugate was a F(ab)2-fragment of antihuman-IgM. In primary infections all patients had significant titre rises of IgG and presence of high IgM titres in the convalescent serum. IgA antibodies were found in all of them, while titre rises were detected in 5/8. In recurrent infections titre rises of IgG and IgA antibodies were found in 4 and 5, respectively. Six had detectable IgM in one or both of the paired samples. The IgG titres were higher in recurrent infections than in primary, in contrast to IgM of which much higher titres were found in primary infections. It is concluded that in primary infections a conclusive serological diagnosis was established in all patients, whereas in recurrent infections this was achieved in two of three patients. The indirect ELISA method used for IgM detection was sensitive, reliable and convenient. Interfering rheumatoid factor was effectively eliminated by treatment with antihuman IgG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840451     DOI: 10.1016/0166-0934(88)90039-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Protective effect of human heat shock protein 60 suggested by its association with decreased seropositivity to pathogens.

Authors:  A Steptoe; A Shamaei-Tousi; A Gylfe; L Bailey; S Bergström; A R Coates; B Henderson
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid.

Authors:  P Doornenbal; G Seerp Baarsma; W G Quint; A Kijlstra; P H Rothbarth; H G Niesters
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

3.  Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.

Authors:  D W Ho; P R Field; W L Irving; D R Packham; A L Cunningham
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

4.  Biological Plausibility of a Link Between Arterial Ischemic Stroke and Infection With Varicella-Zoster Virus or Herpes Simplex Virus.

Authors:  Charles Grose
Journal:  Circulation       Date:  2016-01-26       Impact factor: 29.690

5.  B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin.

Authors:  Emily S Ford; Anton M Sholukh; RuthMabel Boytz; Savanna S Carmack; Alexis Klock; Khamsone Phasouk; Danica Shao; Raabya Rossenkhan; Paul T Edlefsen; Tao Peng; Christine Johnston; Anna Wald; Jia Zhu; Lawrence Corey
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

6.  Herpes virus seroepidemiology in the adult Swedish population.

Authors:  Jan Olsson; Eloise Kok; Rolf Adolfsson; Hugo Lövheim; Fredrik Elgh
Journal:  Immun Ageing       Date:  2017-05-10       Impact factor: 6.400

7.  VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease.

Authors:  Bodil Weidung; Eva-Stina Hemmingsson; Jan Olsson; Torbjörn Sundström; Kaj Blennow; Henrik Zetterberg; Martin Ingelsson; Fredrik Elgh; Hugo Lövheim
Journal:  Alzheimers Dement (N Y)       Date:  2022-03-14

8.  Antiviral treatment associated with reduced risk of clinical Alzheimer's disease-A nested case-control study.

Authors:  Eva-Stina Hemmingsson; Ellen Hjelmare; Bodil Weidung; Jan Olsson; Maria Josefsson; Rolf Adolfsson; Lars Nyberg; Fredrik Elgh; Hugo Lövheim
Journal:  Alzheimers Dement (N Y)       Date:  2021-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.